In human breast, gastric, skin, head and neck and possibly other cancers however, ATBF1 is often mislocalized to the cytoplasm, and the mislocalization is associated with histopathologic progression and worse patient survival [10], [15], [19]. This evidence concerns the gene ZFHX3 and cancer.